327 related articles for article (PubMed ID: 23283935)
1. Aldosterone mediates its rapid effects in vascular endothelial cells through GPER activation.
Gros R; Ding Q; Liu B; Chorazyczewski J; Feldman RD
Am J Physiol Cell Physiol; 2013 Mar; 304(6):C532-40. PubMed ID: 23283935
[TBL] [Abstract][Full Text] [Related]
2. Vascular effects of aldosterone: sorting out the receptors and the ligands.
Feldman RD; Gros R
Clin Exp Pharmacol Physiol; 2013 Dec; 40(12):916-21. PubMed ID: 23902478
[TBL] [Abstract][Full Text] [Related]
3. Delineating the receptor mechanisms underlying the rapid vascular contractile effects of aldosterone and estradiol.
Gros R; Ding Q; Davis M; Shaikh R; Liu B; Chorazyczewski J; Pickering JG; Feldman RD
Can J Physiol Pharmacol; 2011 Sep; 89(9):655-63. PubMed ID: 21854125
[TBL] [Abstract][Full Text] [Related]
4. GPER-independent effects of estrogen in rat aortic vascular endothelial cells.
Ding Q; Hussain Y; Chorazyczewski J; Gros R; Feldman RD
Mol Cell Endocrinol; 2015 Jan; 399():60-8. PubMed ID: 25150623
[TBL] [Abstract][Full Text] [Related]
5. Rapid vascular effects of steroids - a question of balance?
Feldman RD; Gros R
Can J Cardiol; 2010 Mar; 26 Suppl A():22A-26A. PubMed ID: 20386756
[TBL] [Abstract][Full Text] [Related]
6. GPR30 expression is required for the mineralocorticoid receptor-independent rapid vascular effects of aldosterone.
Gros R; Ding Q; Sklar LA; Prossnitz EE; Arterburn JB; Chorazyczewski J; Feldman RD
Hypertension; 2011 Mar; 57(3):442-51. PubMed ID: 21242460
[TBL] [Abstract][Full Text] [Related]
7. Correlation of functional and radioligand binding characteristics of GPER ligands confirming aldosterone as a GPER agonist.
Ding Q; Chorazyczewski J; Gros R; Motulsky HJ; Limbird LE; Feldman RD
Pharmacol Res Perspect; 2022 Oct; 10(5):e00995. PubMed ID: 36065843
[TBL] [Abstract][Full Text] [Related]
8. GPER inhibits diabetes-mediated RhoA activation to prevent vascular endothelial dysfunction.
Li Z; Cheng L; Liang H; Duan W; Hu J; Zhi W; Yang J; Liu Z; Zhao M; Liu J
Eur J Cell Biol; 2016 Feb; 95(2):100-13. PubMed ID: 26785611
[TBL] [Abstract][Full Text] [Related]
9. Aldosterone regulates vascular reactivity: short-term effects mediated by phosphatidylinositol 3-kinase-dependent nitric oxide synthase activation.
Liu SL; Schmuck S; Chorazcyzewski JZ; Gros R; Feldman RD
Circulation; 2003 Nov; 108(19):2400-6. PubMed ID: 14557368
[TBL] [Abstract][Full Text] [Related]
10. Aldosterone mediates metastatic spread of renal cancer via the G protein-coupled estrogen receptor (GPER).
Feldman RD; Ding Q; Hussain Y; Limbird LE; Pickering JG; Gros R
FASEB J; 2016 Jun; 30(6):2086-96. PubMed ID: 26911792
[TBL] [Abstract][Full Text] [Related]
11. GPER is involved in the stimulatory effects of aldosterone in breast cancer cells and breast tumor-derived endothelial cells.
Rigiracciolo DC; Scarpelli A; Lappano R; Pisano A; Santolla MF; Avino S; De Marco P; Bussolati B; Maggiolini M; De Francesco EM
Oncotarget; 2016 Jan; 7(1):94-111. PubMed ID: 26646587
[TBL] [Abstract][Full Text] [Related]
12. Antagonistic Roles of GRK2 and GRK5 in Cardiac Aldosterone Signaling Reveal GRK5-Mediated Cardioprotection via Mineralocorticoid Receptor Inhibition.
Maning J; McCrink KA; Pollard CM; Desimine VL; Ghandour J; Perez A; Cora N; Ferraino KE; Parker BM; Brill AR; Aukszi B; Lymperopoulos A
Int J Mol Sci; 2020 Apr; 21(8):. PubMed ID: 32326036
[TBL] [Abstract][Full Text] [Related]
13. The effects of (-)-epicatechin on endothelial cells involve the G protein-coupled estrogen receptor (GPER).
Moreno-Ulloa A; Mendez-Luna D; Beltran-Partida E; Castillo C; Guevara G; Ramirez-Sanchez I; Correa-Basurto J; Ceballos G; Villarreal F
Pharmacol Res; 2015 Oct; 100():309-20. PubMed ID: 26303816
[TBL] [Abstract][Full Text] [Related]
14. Glucocorticoid-related signaling effects in vascular smooth muscle cells.
Molnar GA; Lindschau C; Dubrovska G; Mertens PR; Kirsch T; Quinkler M; Gollasch M; Wresche S; Luft FC; Muller DN; Fiebeler A
Hypertension; 2008 May; 51(5):1372-8. PubMed ID: 18347231
[TBL] [Abstract][Full Text] [Related]
15. Sensitivity of NOS-dependent vascular relaxation pathway to mineralocorticoid receptor blockade in caveolin-1-deficient mice.
Pojoga LH; Adamová Z; Kumar A; Stennett AK; Romero JR; Adler GK; Williams GH; Khalil RA
Am J Physiol Heart Circ Physiol; 2010 Jun; 298(6):H1776-88. PubMed ID: 20363891
[TBL] [Abstract][Full Text] [Related]
16. Activation of G protein-coupled estrogen receptor induces endothelium-independent relaxation of coronary artery smooth muscle.
Yu X; Ma H; Barman SA; Liu AT; Sellers M; Stallone JN; Prossnitz ER; White RE; Han G
Am J Physiol Endocrinol Metab; 2011 Nov; 301(5):E882-8. PubMed ID: 21791623
[TBL] [Abstract][Full Text] [Related]
17. Vasodilation by GPER in mesenteric arteries involves both endothelial nitric oxide and smooth muscle cAMP signaling.
Lindsey SH; Liu L; Chappell MC
Steroids; 2014 Mar; 81():99-102. PubMed ID: 24246735
[TBL] [Abstract][Full Text] [Related]
18. Extent of Vascular Remodeling Is Dependent on the Balance Between Estrogen Receptor α and G-Protein-Coupled Estrogen Receptor.
Gros R; Hussain Y; Chorazyczewski J; Pickering JG; Ding Q; Feldman RD
Hypertension; 2016 Nov; 68(5):1225-1235. PubMed ID: 27698063
[TBL] [Abstract][Full Text] [Related]
19. G protein-coupled estrogen receptor activation improves contractile and diastolic functions in rat renal interlobular artery to protect against renal ischemia reperfusion injury.
Chang Y; Han Z; Zhang Y; Zhou Y; Feng Z; Chen L; Li X; Li L; Si JQ
Biomed Pharmacother; 2019 Apr; 112():108666. PubMed ID: 30784936
[TBL] [Abstract][Full Text] [Related]
20. G protein-coupled estrogen receptor inhibits vascular prostanoid production and activity.
Meyer MR; Fredette NC; Barton M; Prossnitz ER
J Endocrinol; 2015 Oct; 227(1):61-9. PubMed ID: 26303299
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
